Upgrade to SI Premium - Free Trial

Revolution Medicines' daraxonrasib gets positive EU panel opinion

October 15, 2026 9:46 AM
Revolution Medicines, Inc. (NASDAQ: RVMD) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA